Great to have some info on number of MACs and percentage of market impacted. Medicaid coverage, followed by private funding would surely be significant factors affecting our potential market size. The upside is most people value their sight and vision impairment is a significant public cost, so there is significant motivation at personal, insurance and government levels to fund procedures.
Ann: Pause in Trading, page-50
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $57.20M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 24.0¢ | $26.12K | 108K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4115 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 35419 | 3 |
View Market Depth
| Last trade - 10.55am 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
24.5¢ |
Change
-0.010 ( 2.00 %) |
||||
| Open | High | Low | Volume | ||
| 24.5¢ | 24.5¢ | 24.5¢ | 4000 | ||
| Last updated 10.55am 17/05/2024 ? | |||||
| EYE (ASX) Chart |